arrow
Back
M

Maximilian Strobl

h lee moffitt cancer center & research institute

14H-index
114Paper Count
685Citation Count
Published Papers 24
Publication Date
Deriving Optimal Treatment Timing for Adaptive Therapy: Matching the Model to the Tumor Dynamics
err2025-09-08
err0
errOAAI
errGallagher, Kit; Strobl, Maximilian A. R.; Anderson, Alexander R. A.; Maini, Philip K.
errShare
errSave
To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy
err2024-06-01
err2
PREAI
errStrobl, Maximilian A. R.; Martin, Alexandra L.; West, Jeffrey; Gallaher, Jill; Robertson-Tessi, Mark; Gatenby, Robert; Wenham, Robert; Maini, Philip K.; Damaghi, Mehdi; Anderson, Alexander R. A.
errShare
errSave
Mathematical Model-Driven Deep Learning Enables Personalized Adaptive Therapy
err2024-04-03
err3
errOAAI
errGallagher, Kit; Strobl, Maximilian A. R.; Park, Derek S.; Spoendlin, Fabian C.; Gatenby, Robert A.; Maini, Philip K.; Anderson, Alexander R. A.
errShare
errSave
Integrating mathematical modeling and in vitro experiments to measure ecological interactions in cancer
err2024-02-01
err0
PREAI
errStrobl, Maximilian A. R.; Tadele, Dagim S.; Maltas, Jeffrey; Barker-Clarke, Rowan; Dinh, Mina; Scott, Jacob
errShare
errSave
Evolution of evolvability
err2024-02-01
err0
PREAI
errGallaher, Jill A.; Strobl, Maximilian; West, Jeffrey; Roberston-Tessi, Mark; Anderson, Alexander R. A.
errShare
errSave
Learning to adapt: Rational personalization of adaptive therapy using deep reinforcement learning
err2024-02-01
err0
PREAI
errGallagher, Kit; Strobl, Maximilian; Gatenby, Robert; Maini, Philip; Anderson, Alexander
errShare
errSave
Modeling the coevolution of native and CAR T-cells in large B cell lymphoma reveals a potential biomarker for response to therapy
err2024-02-01
err0
PREAI
errGatenbee, Chandler D.; Robertson-Tessi, Mark; Strobl, Maximilian; Schenck, Ryan O.; Ziccheddu, Bachisio; Maura, Francesco; Locke, Frederick; Anderson, Alexander R. A.
errShare
errSave
Drug dependence in cancer is exploitable by optimally constructed treatment holidays (vol 8, pg 147, 2024)
err2023-12-12
err0
errOAAI
errMaltas, Jeff; Killarney, Shane T.; Singleton, Katherine R.; Strobl, Maximilian A. R.; Washart, Rachel; Wood, Kris C.; Wood, Kevin B.
errShare
errSave
Drug dependence in cancer is exploitable by optimally constructed treatment holidays
err2023-11-27
err7
errOAAI
errMaltas, Jeff; Killarney, Shane T.; Singleton, Katherine R.; Strobl, Maximilian A. R.; Washart, Rachel; Wood, Kris C.; Wood, Kevin B.
errShare
errSave
Treatment of evolving cancers will require dynamic decision support
err2023-10-01
err11
errOAAI
errStrobl, M. A. R.; Gallaher, J.; Robertson-Tessi, M.; West, J.; Anderson, A. R. A.
errShare
errSave
Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics
err2023-05-19
err5
errOAAI
errGallaher, Jill; Strobl, Maximilian; West, Jeffrey; Gatenby, Robert; Zhang, Jingsong; Robertson-Tessi, Mark; Anderson, Alexander R. A.
errShare
errSave
Predicting progression in metastatic castrate-sensitive prostate cancer by coupling PSA and testosterone dynamics to a mechanistic mathematical model
err2023-04-04
err0
PREAI
errGallaher, Jill; Strobl, Maximilian; West, Jeffrey; Robertson-Tessi, Mark; Gatenby, Robert; Zhang, Jingsong; Anderson, Alexander R. A.
errShare
errSave
Spatial transcriptomic driven mechanistic model to investigate and predict pathogenesis of oligodendroglioma
err2023-04-04
err0
PREAI
errPrabhakaran, Sandhya; Cho, Heyrim; Strobl, Maximilian; Rockne, Russell; Anderson, Alexander R.
errShare
errSave
Adaptive treatment scheduling of PARP inhibitors in ovarian cancer: Using mathematical modeling to assess clinical feasibility and estimate potential benefits
err2023-04-04
err0
PREAI
errStrobl, Maximilian A.; Martin, Alexandra L.; Gallagher, Christopher; Damaghi, Mehdi; Robertson-Tessi, Mark; Gatenby, Robert; Wenham, Robert M.; Maini, Philip K.; Anderson, Alexander R.
errShare
errSave
Applying the principles of convexity and concavity to guide treatment scheduling of ALK inhibitors in non-small cell lung cancer
err2023-04-04
err0
PREAI
errWest, Jeffrey; Desai, Bina; Strobl, Maximilian; Pierik, Luke; Vander Velde, Robert; Robertson-Tessi, Mark; Marusyk, Andriy; Anderson, Alexander R.
errShare
errSave
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation
err2023-03-23
err29
errOAAI
errWest, Jeffrey; Adler, Fred; Gallaher, Jill; Strobl, Maximilian; Brady-Nicholls, Renee; Brown, Joel; Roberson-Tessi, Mark; Kim, Eunjung; Noble, Robert; Viossat, Yannick; Basanta, David; Anderson, Alexander R. A.
errShare
errSave
Immunosuppressive niche engineering at the onset of human colorectal cancer
err2022-05-15
err0
PREAI
errGatenbee, Chandler D.; Baker, Ann-Marie; Schenck, Ryan O.; Strobl, Maximilian; West, Jeffrey; Robertson-Tessi, Mark; Graham, Trevor A.; Anderson, Alexander R. A.
errShare
errSave
Antifragile therapy
err2022-05-15
err0
PREAI
errWest, Jeffrey; Desai, Bina; Strobl, Maximilian; Pierik, Luke; Miles, Richard; Armagost, Cole; Robertson-Tessi, Mark; Marusyk, Andriy; Anderson, Alexander R. A.
errShare
errSave
Immunosuppressive niche engineering at the onset of human colorectal cancer
err2022-05-15
err0
PREAI
errGatenbee, Chandler D.; Baker, Ann-Marie; Schenck, Ryan O.; Strobl, Maximilian; West, Jeffrey; Robertson-Tessi, Mark; Graham, Trevor A.; Anderson, Alexander R. A.
errShare
errSave
Integrating mathematical modelling and wet-lab experiments to examine the scope for adaptive treatment scheduling of PARP inhibitors in ovarian cancer
err2022-05-15
err0
PREAI
errStrobl, Maximilian; Damaghi, Mehdi; Martin, Alexandra; Byrne, Samantha; Robertson-Tessi, Mark; Gatenby, Robert; Wenham, Robert; Maini, Philip; Anderson, Alexander R. A.
errShare
errSave